eGVHD 17+
Graft Versus Host Disease
nexuzhealth NV
Designed for iPad
-
- Free
Screenshots
Description
The “eGVHD App” is developed by the UZ Leuven (Belgium) in collaboration with the EBMT (European Bone Marrow Transplantation Society) Transplantation Complications Working Party and the National Institute of Health (Bethesda, USA).
It is an electronic tool designed as an algorithm-driven application, to help clinicians apply the internationally recognized criteria for the assessment of graft versus host disease (GVHD), a pleiotropic disease affecting allogeneic stem cell transplantation recipients when their transplanted stem cells react against their own body.
This app is not a medical tool aiming at replacing the diagnosis of a clinician, but a user-friendly educational tool. It helps health care professionals improve their ability to diagnose and score the severity of GVHD by showing the user differential information and it making an automatic summary of what has been filled in.
What’s New
Version 1.1.1
- CE mark (Class I medical device)
- Minor changes to the algorithms for scoring gvhd
Ratings and Reviews
App Privacy
The developer, nexuzhealth NV, has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy.
No Details Provided
The developer will be required to provide privacy details when they submit their next app update.
Information
- Seller
- nexuzhealth NV
- Size
- 84.7 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 9.0 or later.
- iPad
- Requires iPadOS 9.0 or later.
- iPod touch
- Requires iOS 9.0 or later.
- Mac
- Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 17+ Frequent/Intense Medical/Treatment Information
- Copyright
- © 2018 UZ Leuven
- Price
- Free